Gaurav Chatterjee

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 57 publications

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Clinical Relevance of Genomics Defined WHO5 Subtypes of Pediatric B-ALL in the Context of Measurable Residual Disease-Directed Risk-Based Therapy.

Journal: JCO global oncology

Published: September 03, 2026

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.

Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India.

Journal: Cytometry. Part B, Clinical cytometry

Published: April 12, 2026

Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Journal: JCO global oncology

Published: February 20, 2026

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Detailed analysis of TRBC1 distribution in T-cell subsets and its application in T-cell clonality assessment.

Journal: Cytometry. Part B, Clinical cytometry

Published: February 01, 2026

Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.

Venetoclax induces mitochondrial apoptosis and autophagy to overcome arsenic trioxide resistance in acute promyelocytic leukemia.

Journal: Journal of translational medicine

Published: December 17, 2025

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Utility of multiparametric flow cytometry in the diagnosis and staging of Classic Hodgkin lymphoma-Experience in real-world practice.

Journal: Cytometry. Part B, Clinical cytometry

Published: December 10, 2025

Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?

Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality?

Journal: Journal of clinical pathology

Published: October 01, 2025

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Prevalence and Prognostic Impact of NPM1 Mutation in Childhood Acute Myeloid Leukemia: Experience from a Single Tertiary Cancer Centre in India.

Journal: Clinical lymphoma, myeloma & leukemia

Published: September 27, 2025

Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.

Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.

Journal: Blood cancer journal

Published: July 22, 2025

Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.

Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.

Journal: Blood cancer journal

Published: June 28, 2025

Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for India.

Changing paradigms in pediatric cancer care - the contemporary landscape and perspectives for India.

Journal: Ecancermedicalscience

Published: January 13, 2025

Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma.

Moving Beyond G-CSF Mobilization-Learning From a 15-Year Experience of Different Stem Cell Mobilization Regimens in Multiple Myeloma.

Journal: Cancer medicine

Published: October 22, 2024

Showing 1-12 of 57

Last Updated: 09/26/2026